Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01589042 · ClinicalTrials.gov registry record
Chocolate Balloon Angioplasty Registry
A clinical trial, sponsored by TriReme Medical.
- Completed
- Registry status
- 490
- Enrollment target
NCT01589042: Completed study, sponsored by TriReme Medical.
NCT01589042 is a clinical trial that has completed, run by TriReme Medical. The registered enrollment target is 490 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01589042 has completed, sponsored by TriReme Medical.
- COMPLETED
- Registry status
- 490 participants
- Enrollment target
Study Summary
To collect data from real-world use with the Chocolate PTA Balloon Catheter to support the effectiveness of the device for use during percutaneous transluminal angioplasty (PTA) procedures.
Primary Outcome
Percentage of PTA cases in which \<30% diameter stenosis without a flow limiting dissection is achieved without the need for bail-out stenting
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 490 participants |
| Start Date | 2012-05 |
| Est. Completion | 2015-12 |
What the finished NCT01589042 record still lists
NCT01589042 is an observational study that tracks outcomes without assigning an intervention. The registered 490 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01589042 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01589042 about?
NCT01589042 is a clinical study titled "Chocolate Balloon Angioplasty Registry". To collect data from real-world use with the Chocolate PTA Balloon Catheter to support the effectiveness of the device for use during percutaneous transluminal angioplasty (PTA) procedures.
What is the current status of trial NCT01589042?
This trial is currently completed. The enrollment target is 490 participants. The study started on 2012-05. Estimated completion is 2015-12.
Who is sponsoring clinical trial NCT01589042?
This trial is sponsored by TriReme Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04728893 · 490 participants · Phase 2
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
- NCT06238479 · 490 participants · Phase 1
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
- NCT06336928 · 490 participants
A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis
- NCT06641414 · 490 participants · Phase 3
Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia